Trial Profile
A Multi-Institutional Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jan 2019
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Gemcitabine
- Indications Carcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 14 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.